Patent: 9,161,978
✉ Email this page to a colleague
Summary for Patent: 9,161,978
Title: | Methods of treatment of pterygium using an anti-VEGF agent |
Abstract: | Methods for treating pterygium recurrence following pterygiectomy, and for treating keloid recurrence, following surgical removal of the keloid, are disclosed. The methods include administering an anti-VEGF agent (e.g., antibody (e.g., bevacizumab) or small molecule inhibitor of VEGF signaling), or a combination therapy that includes co-administering an anti-VEGF agent, with an anti-inflammatory steroid and/or a non-steroidal anti-inflammatory drug (NSAID) to a subject. |
Inventor(s): | Pham; Randal Tanh Hoang (San Jose, CA) |
Assignee: | |
Application Number: | 14/261,198 |
Patent Claims: | see list of patent claims |
Details for Patent 9,161,978
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2032-12-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |